Ministry of Health ServicesGoverment of British Columbia
Pharmacare Program
| Home | SA Criteria | SA Forms | RDP | LCA |
Non Steroidal Anti Inflammatory Drugs - Special Authority Criteria

Generic Name / Strength / Form
indomethacin - regular release forms

Criteria Approval Period
1. Diagnosis of rheumatoid or psoriatic arthritis or ankylosing spondylitis or gout or lupus.

OR

2. Treatment failure or intolerance to at least one of the following: ASA-enteric, naproxen, or ibuprofen.

 Indefinite

Practitioner Exemptions

  • Rheumatologists

Special Notes

  • Group 2 NSAID
  • Topical indomethacin is not eligible for Pharmacare coverage.
  • Suppositories are regular benefits and not subject to the RDP.

Online Form (PDF)
Click on the link to complete a special authority request form.

PDF Format

Some documents on this Web site are in PDF format and require a PDF reader. If you do not have Adobe Acrobat Reader Version 7.0 or the most recent version of another PDF reader, you can download Adobe Acrobat Reader by selecting the 'Get Acrobat Reader' icon. Get Acrobat Reader Icon

Back To Top

Last Revised: June 07, 2007

blank space for alignment
Go to TopGo to CopyrightGo to DisclaimerGo to Privacy StatementGo to Feedback Form
blank space for alignment blank space for alignment blank space for alignment blank space for alignment blank space for alignment blank space for alignment